💊 药物 A-Z 🧬 靶点 🛠 工具 📚 指南
全部药物 药物分类 治疗领域 不良反应
指南 术语表 时间轴
药物比较 药物旅程 药物家族
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Seractide Acetate

CHEMBL1201489 Phase 4 已批准 Protein
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
4619.0 g/mol
LogP
—
Phase
4

Seractide acetate is a synthetic tetracosactide (ACTH 1-24) peptide, the biologically active N-terminal fragment of adrenocorticotropic hormone (ACTH), used diagnostically to assess adrenal cortex function and therapeutically for its corticosteroid-stimulating and direct melanocortin receptor-mediated anti-inflammatory effects. By binding to MC2R receptors on adrenal cortical cells, it stimulates rapid cortisol and aldosterone synthesis and secretion. It is used in the short and prolonged Synacthen tests to evaluate adrenal insufficiency.

分子量

4619.0000 g/mol

TPSA

1900.00 Ų

作用机制

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

SMILES

C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]7CCCN7C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC8=CNC9=CC=CC=C98)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CO)N.CC(=O)O.O

InChI

InChI=1S/C207H308N56O58S.C2H4O2.H2O/c1-108(2)89-140(186(302)241-136(70-75-163(279)280)181(297)254-149(204(320)321)94-117-43-20-15-21-44-117)250-193(309)152-54-35-86-262(152)202(318)147(92-116-41-18-14-19-42-116)252-171(287)114(11)230-174(290)134(68-73-161(275)276)235-170(286)113(10)231-191(307)150(105-265)255-182(298)133(66-71-156(213)269)240-190(306)146(98-165(283)284)249-179(295)132(67-72-160(273)274)233-157(270)101-225-169(285)112(9)229-185(301)145(97-164(281)282)251-194(310)153-55-36-87-263(153)203(319)148(93-119-60-64-123(268)65-61-119)253-199(315)167(110(5)6)257-184(300)129(49-26-30-79-210)243-198(314)168(111(7)8)259-196(312)155-57-38-85-261(155)201(317)139(53-34-83-223-207(218)219)244-177(293)130(51-32-81-221-205(214)215)237-176(292)128(48-25-29-78-209)236-175(291)127(47-24-28-77-208)232-158(271)103-227-197(313)166(109(3)4)258-195(311)154-56-37-84-260(154)200(316)138(50-27-31-80-211)234-159(272)102-226-173(289)143(95-120-99-224-126-46-23-22-45-124(120)126)247-178(294)131(52-33-82-222-206(216)217)238-187(303)142(90-115-39-16-13-17-40-115)246-189(305)144(96-121-100-220-107-228-121)248-180(296)135(69-74-162(277)278)239-183(299)137(76-88-322-12)242-192(308)151(106-266)256-188(304)141(245-172(288)125(212)104-264)91-118-58-62-122(267)63-59-118;1-2(3)4;/h13-23,39-46,58-65,99-100,107-114,125,127-155,166-168,224,264-268H,24-38,47-57,66-98,101-106,208-212H2,1-12H3,(H2,213,269)(H,220,228)(H,225,285)(H,226,289)(H,227,313)(H,229,301)(H,230,290)(H,231,307)(H,232,271)(H,233,270)(H,234,272)(H,235,286)(H,236,291)(H,237,292)(H,238,303)(H,239,299)(H,240,306)(H,241,302)(H,242,308)(H,243,314)(H,244,293)(H,245,288)(H,246,305)(H,247,294)(H,248,296)(H,249,295)(H,250,309)(H,251,310)(H,252,287)(H,253,315)(H,254,297)(H,255,298)(H,256,304)(H,257,300)(H,258,311)(H,259,312)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,320,321)(H4,214,215,221)(H4,216,217,222)(H4,218,219,223);1H3,(H,3,4);1H2/t112-,113-,114-,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,166-,167-,168-;;/m0../s1

Molecular Formula

C209H314N56O61S

HBD / HBA

65 / 71

可旋转键数

148

重原子数

327

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Seractide acetate is a synthetic tetracosactide (ACTH 1-24) peptide, the biologically active N-terminal fragment of adrenocorticotropic hormone (ACTH), used diagnostically to assess adrenal cortex function and therapeutically for its corticosteroid-stimulating and direct melanocortin receptor-mediated anti-inflammatory effects. By binding to MC2R receptors on adrenal cortical cells, it stimulates rapid cortisol and aldosterone synthesis and secretion. It is used in the short and prolonged Synacthen tests to evaluate adrenal insufficiency.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Seractide Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201489. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 118984407. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.